News

A recent Rapid Innovation client speaks to Forbes on the role of health innovation under COVID-19

Published: 1

Ancon Technologies, the owners of patented nanotechnology instruments for detecting microparticles such as aerosols and chemical biomarkers, has been featured in an article from Forbes on the UK’s healthtech startup community.

Rapid Innovation partnered with Ancon in 2019 on developing their air quality business for key markets in South and South East Asia.

Ancon Medical’s ‘electronic nose’ technology offers a faster, more cost-effective and non-invasive means to test for illnesses than convention methods.

Read the full article here.